Dogwood Therapeutics, Inc. - 8-K Filing

Dogwood Therapeutics raised $5M via private placement with Sealbond, a shareholder owning ~63.9% pre-issuance (Items: 1.01 of this Current Report on Form 8-K regarding the private placement is incorporated by reference into this Item 3)

SEC EDGAR ·

Tickers: $DWTX

Read the full article at SEC EDGAR

Part of the story Silence Therapeutics plc - 8-K Filing (3 articles)

More Regulatory news